Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes
Clinical and Translational Science · 2024
DOI: 10.1111/cts.13870 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Vincent Aranzana-Climent und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Meropenem, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The AIDA randomized clinical trial found no significant difference in clinical failure or survival between colistin monotherapy and colistin–meropenem combination therapy in carbapenem‐resistant Gram‐negative infections. The aim of this reverse translational study was to integrate all individual preclinical and clinical pharmacokinetic–pharmacodynamic (PKPD) data from the AIDA trial in a pharmacometric framework to explore whether individualized predictions of bacterial burden were associated with the trial outcomes. The compiled dataset included for each of the 207 patients was (i) information on the infecting Acinetobacter baumannii isolate (minimum inhibitory concentration, checkerboard assay data, and fitness in a murine model), (ii) colistin plasma concentrations and colistin and meropenem dosing history, and (iii) disease scores and demographics. The individual information was integrated into PKPD models, and the predicted change in bacterial count at 24 h for each patient, as well as patient characteristics, was correlated with clinical outcomes using logistic regression. The in vivo fitness was the most important factor for change in bacterial count. A model‐predicted growth at 24 h of ≥2‐log 10 (164/207) correlated positively with clinical failure (adjusted odds ratio, aOR = 2.01). The aOR for one unit increase of other significant predictors were 1.24 for SOFA score, 1.19 for Charlson comorbidity index, and 1.01 for age. This study exemplifies how preclinical and clinical anti‐infective PKPD data can be integrated through pharmacodynamic modeling and identify patient‐ and pathogen‐specific factors related to clinical outcomes – an approach that may improve understanding of study outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Université de Poitiers, PHAR2, Inserm U1070, Poitiers, France.
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- The Adelson School of Medicine, Ariel University, Ariel, Israel.
ORCID-Profile: Vincent Aranzana-Climent, Wisse van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon-Benattar, Nadya Rakovitsky, George L Daikos, Anna Skiada, Emanuele Durante-Mangoni, Ursula Theuretzbacher, Mical Paul, Lena E Friberg
Zitieren
APA
Aranzana-Climent, V., van Os, W., Nutman, A., Lellouche, J., Dishon-Benattar, Y., Rakovitsky, N., Daikos, G. L., Skiada, A., Pavleas, I., Durante-Mangoni, E., Theuretzbacher, U., Paul, M., Carmeli, Y., & Friberg, L. E. (2024). Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes. Clinical and Translational Science. https://doi.org/10.1111/cts.13870
Vancouver
Aranzana-Climent V, van Os W, Nutman A, Lellouche J, Dishon-Benattar Y, Rakovitsky N, et al. Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes. Clinical and Translational Science. 2024. doi:10.1111/cts.13870
BibTeX
@article{AranzanaCliment2024,
author = {Aranzana-Climent, Vincent and van Os, Wisse and Nutman, Amir and Lellouche, Jonathan and Dishon-Benattar, Yael and Rakovitsky, Nadya and Daikos, George L and Skiada, Anna and Pavleas, Ioannis and Durante-Mangoni, Emanuele and Theuretzbacher, Ursula and Paul, Mical and Carmeli, Yehuda and Friberg, Lena E},
title = {Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes},
journal = {Clinical and Translational Science},
year = {2024},
doi = {10.1111/cts.13870}
}
EUVIMED